These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 19492313)

  • 21. Methylphenidate reduces orienting bias in healthy individuals.
    Peled-Avron L; Gelbard Goren H; Brande-Eilat N; Dorman-Ilan S; Segev A; Feffer K; Gvirts Problovski HZ; Levkovitz Y; Barnea Y; Lewis YD; Tomer R
    J Psychopharmacol; 2021 Jun; 35(6):760-767. PubMed ID: 33719709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In for a penny, in for a pound: methylphenidate reduces the inhibitory effect of high stakes on persistent risky choice.
    Campbell-Meiklejohn D; Simonsen A; Scheel-Krüger J; Wohlert V; Gjerløff T; Frith CD; Rogers RD; Roepstorff A; Møller A
    J Neurosci; 2012 Sep; 32(38):13032-8. PubMed ID: 22993421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylphenidate extended release (OROS MPH) for the treatment of antidepressant-related sexual dysfunction in patients with treatment-resistant depression: results from a 4-week, double-blind, placebo-controlled trial.
    Pae CU; Marks DM; Masand PS; Peindl K; Hooper-Wood C; Han C; Mannelli P; Ciccone P; Patkar AA
    Clin Neuropharmacol; 2009; 32(2):85-8. PubMed ID: 19512961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of acute varenicline administration on smoking and eating behavior in humans.
    Stoops WW; Vansickel AR; Glaser PE; Rush CR
    Pharmacol Biochem Behav; 2008 Nov; 91(1):165-9. PubMed ID: 18675291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopaminergic dysfunction in abstinent dexamphetamine users: results from a pharmacological fMRI study using a reward anticipation task and a methylphenidate challenge.
    Schouw ML; De Ruiter MB; Kaag AM; van den Brink W; Lindauer RJ; Reneman L
    Drug Alcohol Depend; 2013 Jun; 130(1-3):52-60. PubMed ID: 23142493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic preexposure to methylphenidate cross-sensitizes methamphetamine in male Japanese quail.
    Rosine BJ; Levi Bolin B; Akins CK
    Behav Pharmacol; 2009 Jul; 20(4):352-5. PubMed ID: 19584711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylphenidate alters brain connectivity after enhanced physical performance.
    King M; van Breda K; Rauch LH; Brooks SJ; Stein DJ; Ipser J
    Brain Res; 2018 Jan; 1679():26-32. PubMed ID: 29107662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder.
    Ramos-Quiroga JA; Corominas M; Castells X; Bosch R; Casas M
    Expert Rev Neurother; 2009 Aug; 9(8):1121-31. PubMed ID: 19673602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trial.
    Cohen-Yavin I; Yoran-Hegesh R; Strous RD; Kotler M; Weizman A; Spivak B
    Clin Neuropharmacol; 2009; 32(4):179-82. PubMed ID: 19644227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopaminergic and noradrenergic modulation of stress-induced alterations in brain activation associated with goal-directed behaviour.
    van Ruitenbeek P; Quaedflieg CW; Hernaus D; Hartogsveld B; Smeets T
    J Psychopharmacol; 2021 Dec; 35(12):1449-1463. PubMed ID: 34519561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting the ergogenic response to methylphenidate.
    King M; Van Breda K; Stein DJ; Lutz K; Rauch HGL
    Eur J Appl Physiol; 2018 Apr; 118(4):777-784. PubMed ID: 29372315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological Cognitive Enhancement in Healthy Individuals: A Compensation for Cognitive Deficits or a Question of Personality?
    Maier LJ; Wunderli MD; Vonmoos M; Römmelt AT; Baumgartner MR; Seifritz E; Schaub MP; Quednow BB
    PLoS One; 2015; 10(6):e0129805. PubMed ID: 26107846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of anxiety-related responses in male rats following prolonged exposure to therapeutic doses of oral methylphenidate.
    Britton GB; Bethancourt JA
    Pharmacol Biochem Behav; 2009 Oct; 93(4):451-9. PubMed ID: 19540871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged methylphenidate treatment alters the behavioral diurnal activity pattern of adult male Sprague-Dawley rats.
    Algahim MF; Yang PB; Wilcox VT; Burau KD; Swann AC; Dafny N
    Pharmacol Biochem Behav; 2009 Mar; 92(1):93-9. PubMed ID: 19028517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Developmental toxicity assessment of d,l-methylphenidate and d-methylphenidate in rats and rabbits.
    Beckman DA; Schneider M; Youreneff M; Tse FL
    Birth Defects Res B Dev Reprod Toxicol; 2008 Oct; 83(5):489-501. PubMed ID: 18924147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perception-Action Integration Is Modulated by the Catecholaminergic System Depending on Learning Experience.
    Eggert E; Bluschke A; Takacs A; Kleimaker M; Münchau A; Roessner V; Mückschel M; Beste C
    Int J Neuropsychopharmacol; 2021 Jul; 24(7):592-600. PubMed ID: 33730752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Paradoxical effect of methylphenidate in the treatment of a patient with severe traumatic brain injury].
    Grønborg P; Liljegren J; Jansen J
    Ugeskr Laeger; 2009 Jun; 171(26):2201-2. PubMed ID: 19671403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of acute dopamine reuptake inhibition on cognitive function during passive hyperthermia.
    Wallace PJ; Schultz Martins R; Scott JS; Steele SW; Greenway MJ; Cheung SS
    Appl Physiol Nutr Metab; 2021 May; 46(5):511-520. PubMed ID: 33232172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Differences in neuronal toxicity and its molecular mechanisms between methamphetamine and methylphenidate].
    Narita M; Asato M; Shindo K; Kuzumaki N; Suzuki T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Jun; 29(3):115-20. PubMed ID: 19663261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of application to two different skin sites on the pharmacokinetics of transdermal methylphenidate in pediatric patients with attention-deficit/hyperactivity disorder.
    González MA; Campbell D; Rubin J
    J Child Adolesc Psychopharmacol; 2009 Jun; 19(3):227-32. PubMed ID: 19519257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.